BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

74 related articles for article (PubMed ID: 23122576)

  • 1. Acromegaly induced by ectopic secretion of GHRH: a review 30 years after GHRH discovery.
    Borson-Chazot F; Garby L; Raverot G; Claustrat F; Raverot V; Sassolas G;
    Ann Endocrinol (Paris); 2012 Dec; 73(6):497-502. PubMed ID: 23122576
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The clinical and biochemical spectrum of ectopic acromegaly.
    Fainstein-Day P; Ullmann TE; Dalurzo MCL; Sevlever GE; Smith DE
    Best Pract Res Clin Endocrinol Metab; 2024 May; 38(3):101877. PubMed ID: 38413286
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acromegaly caused by growth hormone-releasing hormone-producing tumors: long-term observational studies in three patients.
    Biermasz NR; Smit JW; Pereira AM; Frölich M; Romijn JA; Roelfsema F
    Pituitary; 2007; 10(3):237-49. PubMed ID: 17541749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Ectopic acromegaly due to bronchial neuroendocrine tumors: the first description in Russia of three clinical cases].
    Mamedova EO; Przhiyalkovskaya EG; Buryakina SA; Bondarenko EV; Lapshina AM; Pikunov MY; Belaya ZE; Melnichenko GA
    Probl Endokrinol (Mosk); 2024 Feb; 70(1):66-80. PubMed ID: 38433543
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acromegaly caused by a GHRH-producing pancreatic neuroendocrine tumor: a rare manifestation of MEN1 syndrome.
    Koivikko M; Ebeling T; Mäkinen M; Leppäluoto J; Raappana A; Ahtiainen P; Salmela P
    Endocrinol Diabetes Metab Case Rep; 2022 Feb; 2022():. PubMed ID: 35199646
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GHRH secretion from a pancreatic neuroendocrine tumor causing gigantism in a patient with MEN1.
    Srirangam Nadhamuni V; Iacovazzo D; Evanson J; Sahdev A; Trouillas J; McAndrew L; R Kurzawinski T; Bryant D; Hussain K; Bhattacharya S; Korbonits M
    Endocrinol Diabetes Metab Case Rep; 2021 Jun; 2021():. PubMed ID: 34156350
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term treatment with pegvisomant as monotherapy in patients with acromegaly: experience from ACROSTUDY.
    Freda PU; Gordon MB; Kelepouris N; Jonsson P; Koltowska-Haggstrom M; van der Lely AJ
    Endocr Pract; 2015 Mar; 21(3):264-74. PubMed ID: 25370326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Diagnostic challenges and management of a patient with acromegaly due to ectopic growth hormone-releasing hormone secretion from a bronchial carcinoid tumour.
    Kyriakakis N; Trouillas J; Dang MN; Lynch J; Belchetz P; Korbonits M; Murray RD
    Endocrinol Diabetes Metab Case Rep; 2017; 2017():. PubMed ID: 28203372
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The Clinicopathological Spectrum of Acromegaly.
    Akirov A; Asa SL; Amer L; Shimon I; Ezzat S
    J Clin Med; 2019 Nov; 8(11):. PubMed ID: 31766255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Acromegaly: clinical features at diagnosis.
    Vilar L; Vilar CF; Lyra R; Lyra R; Naves LA
    Pituitary; 2017 Feb; 20(1):22-32. PubMed ID: 27812777
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetics of gigantism and acromegaly.
    Hannah-Shmouni F; Trivellin G; Stratakis CA
    Growth Horm IGF Res; 2016; 30-31():37-41. PubMed ID: 27657986
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Acromegaly due to ectopic growth hormone (GH)-releasing hormone (GHRH) production: dynamic studies of GH and ectopic GHRH secretion.
    Barkan AL; Shenker Y; Grekin RJ; Vale WW; Lloyd RV; Beals TF
    J Clin Endocrinol Metab; 1986 Nov; 63(5):1057-64. PubMed ID: 3093517
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tall stature and gigantism in transition age: clinical and genetic aspects-a literature review and recommendations.
    Sada V; Puliani G; Feola T; Pirchio R; Pofi R; Sesti F; De Alcubierre D; Amodeo ME; D'Aniello F; Vincenzi L; Gianfrilli D; Isidori AM; Grossman AB; Sbardella E;
    J Endocrinol Invest; 2024 Apr; 47(4):777-793. PubMed ID: 37891382
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Surgical Management of Pancreatic Neuroendocrine Tumors.
    Sulciner ML; Clancy TE
    Cancers (Basel); 2023 Mar; 15(7):. PubMed ID: 37046665
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and gastrointestinal malignancy: An intriguing link.
    Palui R; Sridharan K; Kamalanathan S; Sahoo J; Naik D
    World J Gastrointest Pathophysiol; 2023 Jan; 14(1):1-11. PubMed ID: 36743656
    [TBL] [Abstract][Full Text] [Related]  

  • 16. EMPTY SELLA IN A PATIENT WITH CLINICAL AND BIOCHEMICAL DIAGNOSIS OF ACROMEGALY.
    Bestepe N; Aydin C; Tam AA; Ercan K; Ersoy R; Cakir B
    Acta Endocrinol (Buchar); 2022; 18(1):97-101. PubMed ID: 35975262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Acromegaly Caused by Ectopic Growth Hormone Releasing Hormone Secretion: A Review.
    Zendran I; Gut G; Kałużny M; Zawadzka K; Bolanowski M
    Front Endocrinol (Lausanne); 2022; 13():867965. PubMed ID: 35757397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ockham's Razor for a Retinal Lesion and Acromegaly and Breaking the Vicious Circle.
    Rak-Makowska B; Khoo B; Sen Gupta P; Plowman PN; Grossman AB; Korbonits M
    J Endocr Soc; 2022 Jul; 6(7):bvac083. PubMed ID: 35702603
    [TBL] [Abstract][Full Text] [Related]  

  • 19.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.